Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
OpenAI CEO Sam Altman, Oracle founder Larry Ellison and SoftBank CEO Masayoshi Son comment on President Trump’s Stargate AI ...
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...